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Pharmaceutical salt solvates (dimethyl sulfoxide, DMSO) of the drug
triamterene with the coformers acetic, succinic, adipic, pimelic, azelaic and
nicotinic acid and ibuprofen are prepared by liquid-assisted grinding and
solvent-evaporative crystallization. The modified pKa rule as proposed by
Cruz-Cabeza [(2012). CrystEngComm, 14, 6362–6365] is in close agreement with
the results of this study. All adducts were characterized by X-ray diffraction and
thermal analytical techniques, including single-crystal X-ray diffraction, powder
X-ray diffraction, differential scanning calorimetry and thermal gravimetric
analysis. Hydrogen-bonded motifs combined to form a variety of extended tapes
and sheets. Analysis of the crystal structures showed that all adducts existed as
salt solvates and contained the aminopyridinium–carboxylate heterodimer,
except for the solvate containing triamterene, ibuprofen and DMSO, as a result
of the presence of a strong and stable hemitriamterenium duplex. A search of
the Cambridge Structural Database (CSD 5.36, Version 1.18) to determine the
frequency of occurrence of the putative supramolecular synthons found in this
study showed good agreement with previous work.
1. Introduction
The compound 2,4,7-triamino-6-phenylpteridine (C12H11N7),
named triamterene (1), is a potassium-sparing diuretic and
modest inhibitor of dihydrofolate reductase. It is marketed
under the name of Dyrenium (Well Spring Pharmaceutical
Corporation, Concordia Pharmaceutical Inc., Carilion Mate-
rials Management and GlaxoSmithKline Inc.) for the treat-
ment of oedema (water retention) and, when combined with
hydrochlorthiazide as Maxzide (Mylan Pharmaceuticals) and
Dyazide (Cardinal Health and SmithKline Beecham), for the
treatment of hypertension (high blood pressure).
This drug has poor solubility in water and a low bioavail-
ability (45 mg ml1) (Dittert et al., 1964), and is therefore an
excellent candidate for a cocrystal or salt screen (Thakuria et
al., 2013; Duggirala et al., 2016). A recent study (Ma et al.,
2013) found two polymorphs of the salt of 1 with
cucurbit[7]uril (CB[7]). The powder of the CB[7] salt forms a
stable complex with 1 in aqueous solution with improved
dissolution and solubility by a factor of 1.6 > 1 in 0.1M
hydrochloric acid. The increased solubility and consequent
oral bioavailability of 1 in this case was attributed to the
formation of a hydrophilic cylinder composed of two hydro-
philic portals containing carbonyl functional groups, in which
two molecules of 1 are encapsulated to form a stable complex.
As an alternative approach, adduct (cocrystal or salt) forma-
tion with carboxylic acids (Bhatt et al., 2009), Generally
Regarded As Safe (GRAS) molecules (Delori et al., 2008;
Aitipamula et al., 2014; Lu & Rohani, 2010) and Active
Pharmaceutical Ingredients (APIs) (Huang et al., 2014; Sowa
et al., 2012; Ba´thori et al., 2011; Delori, Galek et al., 2013;
Grobelny et al., 2011) also provides a means to improve the
physicochemical properties of 1. For example, a recent study by
Li et al. (2015) reportedenhanced solubility anddissolution as a
result of salt formation with dl-mandelic acid and saccharin.
Adduct (cocrystal or salt) formation reactions do not only
find application in modifying solubility and dissolution profiles
(Aitipamula, Vangala et al., 2012; Aitipamula, Wong et al.,
2012; Sanphui et al., 2011) but have also been used in altering
various other physical properties, such as colour (Stahl &
Wermuth, 2008; Pallipurath et al., 2015; Delori et al., 2016),
melting point (Frisˇcˇic´ & Jones, 2010), stability to humidity
(Trask et al., 2005, 2006), tableting properties (Bucˇar et al.,
2015) fluorescence (Bucˇar et al., 2013; Yan et al., 2013) and
polymorphic conversion (Delori et al., 2014).
As shown in Fig. 1, the 2-, 4- and 7-amino groups of the
pteridine ring of 1 have good hydrogen-bond donor ability,
while the N atoms at positions 1, 3, 5 and 8 can act as potential
hydrogen-bond acceptors; however, the N atoms of the amino
groups can also act as acceptors, making a total of six donors
and seven potential hydrogen-bond acceptors. Since 1 has a
large number of potential hydrogen-bond acceptor and donor
sites, as well as the option of ionization to form a salt, it is
particularly interesting from a crystal engineering standpoint.
Furthermore, the cocrystal/salt chemistry of 1 is not well
understood, making it a suitable candidate for further
experimental work.
Within the literature, different strategies have been adopted
for the selection of suitable pharmaceutical coformers. One
method is based on the hydrogen-bond propensity tool (Bhatt
et al., 2009; Delori et al., 2012; Delori, Galek et al., 2013; Huang
et al., 2014; Wood et al., 2014) developed by the Cambridge
Crystallographic Data Centre (CCDC) to predict the possi-
bility of new polymorphs or adducts based on observed
hydrogen bonding in chemically related molecules. Putative
pharmaceutical adducts have also been predicted using the
CCDC software GOLD (Galek et al., 2007, 2010). A further
approach based on molecular shape and polarity descriptors,
as a statistical analysis of the Cambridge Structural Database
(CSD), found these properties to be the most influential in
successful crystal formation (Fa´bia´n, 2009). In the present
study, we select two classes of coformer for initial screening:
mono- and dicarboxylic acids. Within each of these categories,
diversity is created using molecular weight, alkyl or phenyl
character and varying the number of available hydrogen-bond
donors or acceptors (see Fig. S1 in the supporting informa-
tion).
The supramolecular synthon approach is widely used in the
search for potential cocrystal or salt formation (Desiraju,
1995; Varughese et al., 2010; Arhangelskis et al., 2012). This
approach relies on the interaction between complementary
functional groups in the formation of hydrogen-bonded
adducts (Etter, 1991; Etter & Reutzel, 1991; Etter et al., 1990).
In this study, the N1 atom and the 2-amino group in a molecule
of 1 are predicted to interact with the carboxyl functional
group of the carboxylic acid. The predicted R22ð8Þ synthon will
either involve N—H  O and O—H  N (both neutral)
hydrogen bonds to form a cocrystal or N+—H  O (charge
assisted) and N—H  O (neutral) hydrogen bonds to form a
salt (see Fig. 2).
The exact nature of the complex formed is difficult to
predict using only synthon information, details of the mole-
cular recognition process (including kinetics) must also be
considered. For this reason, the pKa rule was applied by
Cheney, Shan et al. (2010) and Cheney, Weyna et al. (2010). It
is widely acknowledged (Childs et al., 2007) that if the calcu-
lated pKa lies in the range 0–3 then prediction becomes
unreliable. An improvement of this method
has subsequently been proposed by Cruz-
Cabeza (2012) and this method is explored in
greater detail during this study.
2. Experimental
Pharmaceutical salt solvates (DMSO) of the
drug triamterene with the coformers (a)
acetic, (b) succinic, (c) adipic, (d) pimelic, (e)
azelaic and (f) nicotinic acid, and (g)
ibuprofen are prepared by liquid-assisted
grinding (LAG) and solvent-evaporative
crystallization (SEC). All chemicals were
purchased from Sigma–Aldrich and used
without further purification. The solvents
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Figure 1
Chemical diagram of 1 labelled with the numbering scheme that is used
throughout this manuscript.
Figure 2
Proposed supramolecular heterosynthons between 1 and the acid coformers.
employed for the crystallizations were spectroscopy grade of
the highest purity available.
2.1. Adduct prediction
The method proposed by Cruz-Cabeza (2012) is explored in
order to predict the outcome of a given adduct formation
reaction where Pobs is the probability (%) of observing AB
(cocrystal) and AB+ (salt).
PobsðAB;%Þ ¼ 17pKa þ 72 ; for 1  pKa  4
PobsðABþ;%Þ ¼ 17pKa þ 28 ; for 1  pKa  4
The Pobs values for the proposed adduct formation reactions
were calculated using the above formulae and compared with
the results obtained by experiment in Table S1.
2.2. Liquid-assisted grinding
LAG experiments were performed by placing 200 mg of a
physical mixture of 1 with the corresponding acid (a–e) in a 1:1
or 2:1 stoichiometric ratio in a 15 ml stainless-steel grinding
jar, accompanied by the addition of 30–50 ml of solvent
(DMSO). Grinding was carried out using a Retsch MM200
mixer mill with a frequency of 30 Hz for 30 min together with
two stainless steel grinding balls of 7 mm diameter.
2.3. Solvent-evaporative crystallization
Crystals of pure triamterene were obtained by dissolving
10 mg of 1 in 30 ml of methanol and the solution was then
heated and filtered prior to SEC. The solutions for the crys-
tallization of 1a–gDMSO were prepared by dissolving the
product of the LAG process (50 mg) in DMSO (2 ml) and to
aid dissolution, the contents were sonicated prior to gentle
heating in a bead bath at 323 K and were filtered (if necessary)
into a suitable vial. Colourless high-quality crystals suitable for
single-crystal X-ray diffraction analysis (SCXRD) were
obtained in all cases by slow evaporation of the methanol or
DMSO solution at room temperature for 3–7 d (see Table S2
for a summary of the crystallization data).
2.4. Single-crystal X-ray diffraction
A search of the CSD (5.36, Version 1.18; Groom et al., 2016)
revealed two crystal structures of 1 with the refcodes FITZAJ
(Schwalbe & Williams, 1987) and FITZAJ01 (Tutughamiarso
& Bolte, 2007). These crystal structures have fairly high R1
values [Fo > 3 and I > 2(I) of 0.09 and 0.0739, respectively]
so in our previous work (Hughes et al., 2017), we redetermined
the crystal structure of 1 (CCDC deposition code: 1532364)
using a crystal grown from methanol. CCDC deposit 1532364
forms the basis for the description of the crystal structure of 1
that follows.
Experimentally, good-quality single crystals of 1a–gDMSO
were chosen by selection under an optical microscope, glued
to a glass fibre and mounted on the goniometer of a Bruker
diffractometer equipped with an APEX CCD detector at low
temperature (150 K for 1dDMSO, 180 K for 1aDMSO,
1cDMSO, 1eDMSO, 1fDMSO and 1gDMSO and 220 K for
1bDMSO) and graphite-monochromated Mo K radiation
( = 0.71073 A˚). In all cases, the data were collected without
complication and all crystals were found to be stable
throughout the collection period. Intensity data were
processed using SAINT (Bruker, 2007), followed by an
absorption correction using SADABS (Bruker, 2001). The
structures for 1a–gDMSO were all solved using SIR92
(Altomare et al., 1993) and were refined using the least-
squares methods employed in SHELXL2013 (Sheldrick,
2015). All non-H atoms were refined using anisotropic
methods, the H atoms either placed in calculated positions by
research papers
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Table 1
Selected crystallographic parameters for 1 and 1a–gDMSO.
1† 1aDMSO 1bDMSO 1cDMSO 1dDMSO 1eDMSO 1fDMSO 1gDMSO
Formula C12H11N7 C12H12N7
+
C2H3O2

C2H6OS
C12H12N7
+
C4H5O4

C2H6OS
2C12H12N7
+
C6H8O4
2
2C2H6OS
2C12H12N7
+
C7H10O4
2
2C2H6OS
2C12H12N7
+
C9H14O4
2
2C2H6OS
C12H12N7
+
C6H4NO2

C12H11N7.
2C2H6OS
C12H12N7
+
C13H17O2

C12H11N7
C2H6OS
Mr 253.28 391.46 449.49 808.95 822.98 851.03 785.92 790.96
Crystal system Triclinic Triclinic Monoclinic Triclinic Triclinic Monoclinic Monoclinic Triclinic
Space group P1 P1 P21/c P1 P1 P21/n P21/n P1
a (A˚) 7.4432 (15) 10.8022 (2) 13.5226 (7) 11.0286 (3) 14.0750 (5) 15.0338 (3) 14.8461 (2) 11.2398 (3)
b (A˚) 9.993 (2) 13.9084 (2) 14.9966 (7) 13.7429 (4) 14.8889 (6) 11.5004 (2) 12.3081 (3) 13.2439 (3)
c (A˚) 16.648 (3) 14.6076 (3) 10.6958 (5) 14.9742 (5) 19.635 (2) 24.3960 (6) 21.2850 (5) 15.4624 (4)
 () 77.55 (2) 115.284 (1) 90 115.247 (2) 86.408 (2) 90 90 113.595 (2)
 () 87.54 (3) 109.088 (2) 104.179 (2) 109.951 (2) 88.142 (2) 104.539 (1) 105.176 (1) 103.527 (2)
 () 87.09 (3) 90.525 (1) 90 90.122 (2) 71.702 (2) 90 90 91.977 (2)
V (A˚3) 1207.0 (4) 1846.64 (6) 2102.95 (18) 1900.24 (11) 3898.7 (5) 4082.87 (15) 3753.71 (14) 2029.46 (9)
Z 4 4 4 2 4 4 4 2
Dcalc (Mg m
1) 1.394 1.408 1.420 1.414 1.402 1.384 1.391 1.294
T (K) 180 (2) 180 (2) 220 (2) 180 (2) 150 (2) 180 (2) 180 (2) 180 (2)
GOF on F2 1.032 0.935 0.747 1.022 0.945 1.033 0.897 1.021
R1 [I > 2(I)] 0.0360 0.0466 0.0364 0.0729 0.0788 0.0587 0.0414 0.0737
wR2 0.0916 0.1179 0.0693 0.1727 0.1951 0.1461 0.0803 0.1891
CCDC 1532364 1579683 1579684 1579685 1579686 1579687 1579688 1579689
† The values for 1 were obtained from the work by Hughes et al. (2017).
refinement or found by experiment (electron density) where
appropriate. The position of the H atom on ring atom N1 was
of particular importance and found by experiment in all cases
except 1dDMSO, as the experimental data for this crystal was
poor. All structure refinements converged to good R factors
and hydrogen bonds were determined using PLATON soft-
ware (Spek, 2009). All diagrams relating to the crystal struc-
ture of 1a–gDMSO were generated using the Mercury 3.9
module of the CSD Enterprise package (Macrae et al., 2008).
Table 1 contains selected crystallographic parameters for 1
and 1a–gDMSO. Table S3 (see supporting information)
contains further crystallographic details relating to data
collection and structure refinement for 1 and 1a–gDMSO.
Table S4 contains details of the labelling scheme for 1 and 1a–
gDMSO, Figs. S2–S9 show the asymmetric units for 1 and 1a–
gDMSO and Tables S5–S12 contain details of the hydrogen
bond schemes for 1 and 1a–gDMSO. The supplementary
crystallographic data (CIF files) for 1a–gDMSO are available
in the supporting information for this article or from the
Cambridge Crystallographic Data Centre. The supporting
information also contains enhanced three-dimensional inter-
active structural files in Mercury (MRYX) format corre-
sponding to Figs. 3–16 in the manuscript.
2.5. Powder X-ray diffraction
Powder X-ray diffraction (PXRD) data were collected on a
Phillips PW3710 diffractometer with nickel-filtered Cu K
radiation (1.5406 A˚) at 40 kV and 40 mA using a scanning
RTMS X’Celerator detector. The samples were prepared by
gently pressing on a glass slide with a sample groove. Data
were collected between 3  2  50 at ambient temperature
with a step size of 0.0167 at a time per step of 13.97 s for a
total scan time of 5 min.
To show that the crystals selected for single-crystal analysis
were representative of the bulk powders obtained by LAG, the
experimental patterns were compared with the simulated
patterns for samples 1a–gDMSO (see Figs. S10–S16 of the
supporting information for reference).
2.6. Differential scanning calorimetry measurements
For differential scanning calorimetry (DSC) analysis, a
standard 40 ml aluminium pan was used by placing 3–7 mg of
gently ground material such that the bottom of the pan was
uniformly covered with sample. The pan was sealed with an
aluminium lid using a press and a small hole made in the lid. A
Mettler Toledo DSC 822 instrument with an 80 cm3 min1
nitrogen purge flow rate was used for the analysis. The
temperature range used was 298–673 K with a scan rate of
10 K min1. Mettler Toledo STARe software (Version 8) was
used for the analysis of thermal data obtained.
DSC results for sample 1 are shown for reference in Fig. S17
(see supporting information).
2.7. Thermometric gravimetric analysis measurements
Samples were prepared by placing 7–13 mg of material in a
standard 100 ml aluminium pan. A Mettler Toledo TGA/
SDTA851e/SF/1100 instrument with an air purge flow rate of
50 cm3 min1 was used for the thermogravimetric analysis
(TGA). The samples were heated at a rate of 10 K min1
between 303–673 K and a data analysis was carried out using
Mettler Toledo STARe software (Version 8).
DSC and TGA curves for samples 1a–gDMSO are shown
in Figs. S18–S24 (supporting information).
3. Results and discussion
All the crystalline adducts in the present study between 1 and
coformers a–g existed as salt solvates (Grothe et al., 2016). The
salt/coformer predictions are summarized in Table S1 and the
results for all the predicted crystalline adducts were in good
agreement with the experiment except for 1aDMSO and
1gDMSO where the pKa values (Hilal et al., 1995) are
smallest, thereby providing support for the validity of the
modified pKa rule of Cruz-Cabeza (2012) in this case.
Exceptions are known to the pKa rule, primarily because of
the fact that pKa is a measure of acidity in aqueous solution
and the acidity of the same molecules in the crystalline state
may be different (Molcˇanov & Kojic´-Prodic´, 2010).
A solvent screen revealed 1 to be generally insoluble in
most common solvents and it also has a low solubility in most
solvents compared with the coformers a–g chosen for this
study. LAG experiments using methanol failed since single
crystals could not be obtained and the melt cocrystallization
experiments were unsuccessful because of the high melting
point difference between 1 and the coformers a–g. For these
reasons, DMSO was employed as the solvent of choice for the
LAG and SEC experiments described in this study since it
could be used in relatively small amounts (LAG, 30–50 ml and
SEC, 2 ml) and yielded crystalline batches that showed good
reproducibility on this scale (see Table S2 for further details).
To enable accurate comparison of the crystal structures, a
consistent numbering scheme is used in this study and is shown
in Fig. 1. If proton transfer occurs then, from the pKa values,
the transfer is expected to occur from the carboxylic acid
group H1X to the most basic ring nitrogen, N1, of 1. The
numbering scheme for molecules of 1 follow IUPAC recom-
mendations for pteridine-like molecules, whilst individual
molecules of 1, coformer and solvent are labelled according to
IUCr rules (see Table S4 for details). All asymmetric units and
lists of hydrogen bonds are included in Figs. S2–S9 and Tables
S5–S12, respectively.
All comparisons of experimental PXRD and simulated
PXRD from SCXRD agree closely (see Figs. S10–S12 and
S14–S16) except for 1dDMSO (see Fig. S13) and this is
thought to be a result of the preferred orientation of the plate-
like crystals noted in this sample.
In an earlier paper (Hughes et al., 2017), we performed a
detailed analysis of the crystal structure of 1. We have used
this knowledge to create a refined version of the graph-set
analysis that can describe the similarities and differences
between the crystal structures obtained in this study. Crucial to
this refinement of graph-set analysis is the concept of the motif
which may be defined as a characteristic pattern of hydrogen
bonds within the crystal structure. These interactions may be
intermolecular, intramolecular or a combination of the two.
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Motifs are sets of interactions between functional groups
creating a particular pattern, e.g. rings, chains or discrete
contacts. Examples of hydrogen-bonding motifs include the
common carboxylic acid ring dimer, the N—H  N chain, and
the amide ring dimer. As an extension of this concept, we have
introduced the term ‘tape motif’ to include groups of two or
more individual motifs and supramolecular synthons defined
by Desiraju (1995) as ‘structural units within supermolecules
which can be formed and/or assembled by known or concei-
vable synthetic operations involving intermolecular interac-
tions’. Using these concepts we are able to describe the crystal
structure with the view of recognizing the important simila-
rities and differences that exist within the group of structures
chosen for this study and beyond.
3.1. The crystal structure of triamterene
The single-crystal data obtained from our earlier paper
demonstrates that 1 crystallizes in the triclinic space group P1
with two independent molecules in the asymmetric unit (Z =
4), as shown in Table 1. The asymmetric unit of 1 is shown in
Fig. S2 and a list of hydrogen bonds is given in Table S5.
The crystal structure shows molecules of A and B linked
into tapes by N—H  N hydrogen bonds between the H atoms
of the 2-amino groups and the N1 and N3 atoms of adjacent
molecules, resulting in the formation of the M1 motif with
graph-set notation R22ð8Þ. Additionally, the M2 motif with
graph-set notation R33 10ð Þ exists from the formation of three
N—H  N hydrogen bonds using the N atoms at positions 1
and 8 interacting with the 2- and 4-amino groups of three
molecules of 1 (see Fig. 3a). The M3 motif joins two molecules
in adjacent tapes through N—H  N hydrogen bonds invol-
ving the 7-amino group (see Fig. 3b). It is worth noting that
although M1 and M3 motifs are both R22ð8Þ homosynthons,
they are numbered differently as they occupy different posi-
tions on the component molecules of 1.
Other ring motifs are present (which are not labelled) that
satisfy the hydrogen-bond donor and acceptor requirements
of 1, but for the purposes of simplification, only the motifs that
occur repeatedly in the subsequent adducts of 1 are consid-
ered in this discussion. The motifs M2, M1 and M2 combine to
form the tape motif TM15 and the hydrogen-bonded tapes
seen in the crystal structure of 1 (see Fig. 3a for details).
Overlapping tapes of 1 (Fig. 3b) create a stepped hydrogen-
bonded sheet using the M3 motif and these adjacent
hydrogen-bonded sheets pack to form the full three-
dimensional crystal structure (as seen in Fig. 3c).
3.2. Salt solvate of triamterene with acetic acid and DMSO
(1aDMSO)
Crystals of adduct 1aDMSO are obtained from a mixture of
1 and a (1:1) in a solution of DMSO to create a crystalline salt
solvate in the triclinic space group P1 (see Table 1). The
asymmetric unit contains two molecules each of 1, coformer
(carboxylic acid) and DMSO. The asymmetric unit of
1aDMSO is shown in Fig. S3 and a table of hydrogen bonds is
included (see Table S6).
The crystal structure shows molecules of 1 interacting with
each other via N—H  N hydrogen bonds, creating the M3
andM4 motifs, both with the graph-set notation R22ð8Þ. 1 is also
protonated at the most basic atom (N1) and the comple-
mentary groups on 1 and a interact through charge-assisted
N+—H  O and neutral N—H  O hydrogen bonds, creating
the M7 motif, also with graph-set notation R22ð8Þ. DMSO
interacts with two molecules of 1 via two N—H  O hydrogen
bonds, in addition to an intermolecular N—H  N bond
between adjacent molecules of 1, which creates the M5 motif
with R23ð8Þ graph-set notation. Motifs M7, M6, M3, M6 and M7
combine to form TM16, and M5, M4 and M5 combine to form
TM17 (see Fig. 4a for details).
These tape motifs create a supramolecular tape of 1 mole-
cules (containing additional acid and solvent molecules) that is
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Figure 3
(a) Motifs M2, M1 and M2 (tape motif TM15) and motif M3 observed in
1. (b) The view along c illustrating the relationship between adjacent
tapes using the M3 motif (side view). (c) Packing diagram of the stepped
hydrogen-bonded sheets.
interlinked to an adjacent tape of 1 through (C—H  O) weak
hydrogen bonds that create voids in the crystal structure (Fig.
4a). Around each void, hydrogen-bonded molecules of 1
create A and B cyclic networks. In the A cyclic network, two
DMSO molecules occupy the void; however, in the B network,
the acid molecules protrude into the void.
The expansion of these combined (A and B) cyclic networks
in two dimensions results in the formation of a hydrogen-
bonded sheet formed by stepped tapes similar to that seen in 1
and shown in Fig. 4(b) using a space-filling representation.
3.3. Salt solvate of triamterene with succinic acid and DMSO
(1bDMSO)
1bDMSO crystallizes from DMSO solution as a salt solvate
in the monoclinic P21/c space group (see Table 1). The
asymmetric unit contains one molecule each of 1, b and
DMSO (1:1:1). The asymmetric unit of 1bDMSO is shown in
Fig. S4 and the hydrogen bonds are given in Table S7. It can be
seen from the asymmetric unit that only one of the two
carboxylic acid groups of b is deprotonated and the H atom is
transferred to the most basic atom (N1) of 1; the other
carboxyl group is involved in an intramolecular O—H  O
hydrogen bond and is therefore not available for deproton-
ation.
The crystal structure of 1bDMSO arises from the formation
of two types of hydrogen-bonded network, namely A, which is
a ten-membered cyclic hydrogen-bonded network, and B, a
six-membered cyclic hydrogen-bonded network similar to that
seen in 1aDMSO. Furthermore, the A network involves two
sets of three molecules (trimers) of 1 linked by the M8 motif
that interact with two b molecules through the M7 motif
present in 1aDMSO (see Fig. 5). Two DMSO molecules act as
a bridge between 1 and b creating the M9 motif and
completing the ten-membered cyclic network. The cavity
created by theA network is filled by two phenyl rings of 1 and,
if these phenyl rings are flipped away from the cavity, voids of
12.7  9.0 A˚ are created. In cyclic network B, two single
molecules of 1 connect with two molecules of b, creating two
M7 motifs, and the two DMSO molecules protrude into the
cavity formed by 1, with b acting as a bridge, joined to 1 by
hydrogen bonds and completing the six-membered cyclic
network (Fig. 5). We note that in the crystal structure the
cyclic networks are made by 1, b and solvent molecules
(Fig. 5), as opposed to only 1 and a in 1aDMSO. Motifs M7,
M10, M8 and M9 combine to create the tape motif TM18, M8
and M9 form TM19, and M7, M10 and M8 form TM20, and so
complete the hydrogen-bond description of the tape structure
found in 1bDMSO.
Further expansion of the hydrogen-bonded tape structure
in the second dimension results in a sheet structure in which
rows of M8 motifs of 1 are interconnected through carboxylic
research papers
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Figure 4
(a) Motifs M7, M6, M3, M6 and M7 (TM16), and M5, M4 and M5 (TM17)
found in the crystal structure of 1aDMSO. (b) The host–guest network in
the form of stepped tapes forming a sheet structure.
Figure 5
The cyclic hydrogen-bonded networks A and B of the crystal structure of
1bDMSO.
Figure 6
Motifs M7, M10, M8 and M9 (TM18), M8 and M9 (TM19), and M7, M10
and M8 (TM20) observed in the hydrogen-bonded sheets of 1bDMSO.
acid and solvent molecules by weak hydrogen bonds (see
Fig. 6 for details).
3.4. Salt solvate of triamterene with adipic acid and DMSO
(1cDMSO)
Crystallization of 1 and c from DMSO generated a 2:1 salt
(21+c2) together with two molecules of DMSO in the triclinic
space group P1 (see Table 1); c acts as a proton donor by the
deprotonation of both protons of the carboxylic acids. The
asymmetric unit is shown in Fig. S5 and contains two mole-
cules of 1, one of c and two of DMSO (2:1:2). One DMSO
molecule is found to be disordered over two sites with occu-
pancies of 0.7 and 0.3. For the purposes of the crystal structure
refinement, geometric constraints and a common isotropic
displacement parameter for the non-H atoms were applied to
both. A list of hydrogen bonds for 1cDMSO is given in
Table S8.
The crystal structure is a host–guest assembly, with the
framework created by molecules of 1 and c, as shown in Figs.
7(a) and 7(b). The interaction between 1 and c is through the
M7 motif seen in earlier structures, while the molecules of 1
interlink through M3 and M4 motifs (also present in
1aDMSO) to form two sets of three molecules (trimers)
which link to form sheets. The trimers (tapes) also connect
with each other through two acid molecules by hydrogen
bonding. This results in the formation of an eight-membered
cyclic host network with a cavity of 10.0  15.3 A˚ containing
the two molecules of DMSO, as shown in Fig. 7(b).
Motifs M5, M4 and M5 (TM16), and M7, M6, M3, M6 and
M7 (TM17) create the hydrogen-bonded network structure
(see Fig. 8). Such host–guest assemblies are well known in the
field of supramolecular chemistry (Bhatt et al., 2009; Galcera et
al., 2012).
3.5. Salt solvate of triamterene with pimelic acid (1dDMSO)
The molecular adduct of 1dDMSO crystallizes in the
triclinic P1 space group (see Table 1) as a salt between 1 and d
in which the acid is found to be doubly deprotonated, trans-
ferring protons to two separate molecules of the most basic
atom (N1) of 1. The asymmetric unit of the crystal structure is
shown in Fig. S6 and contains four molecules of 1 (A, B, C and
D), two molecules of d (E and F) and two molecules of DMSO
(G). Hydrogen-bond details for 1dDMSO are given in
Table S9.
In the crystal structure, molecules of 1 are connected via
N—H  N hydrogen bonds joined by M8 motifs to form
trimers. The acid molecules act as spacers between the trimers
joined by the M7 motif and create a zigzag crinkled supra-
molecular sheet (Fig. 9a), as seen in 1bDMSO (see Fig. 6). As
noted earlier, this tape is fundamentally different from the
supramolecular tape found in 1cDMSO (see Fig. 7) since, in
this case, motifs M3 and M4 are not involved in creating a
trimer of 1 molecules.
Expansion of the supramolecular tape in the second
dimension results in a cyclic eight-membered host network,
creating a cavity of 14.9  9.1 A˚ (Fig. 9a). This cavity is filled
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Figure 7
(a) The eight-membered hydrogen-bonded cyclic host network with a
cavity of 15.3  10.0 A˚ dimensions and (b) the cavity filled with two
DMSO molecules as guests in 1cDMSO.
Figure 8
Motifs M5, M4 and M5 (TM16), and M7, M6, M3, M6 and M7 (TM17)
found in the hydrogen-bonded sheets of 1cDMSO.
with two DMSO molecules that act as guests joined to the
tapes by M9 motifs with the phenyl rings of 1 also extending
into the space (Fig. 9a). Motifs M7, M10, M8 and M9 (TM18),
M8 and M9 (TM19), and M7, M10 and M8 (TM20) are also
found in the hydrogen-bonded sheet (see Fig. 9b).
A hydrogen-bonded sheet structure formed by the combi-
nation of host–guest networks is shown in Fig. 9(c) in which
molecular tapes of M8 motifs interconnect with M7 motifs
with the acid. Tape motifs TM18, TM19 and TM20 are also
found in the hydrogen-bonded sheet seen earlier in 1bDMSO.
The zigzag stacking of the molecules in this structure is
represented by a space-filling model (viewed along the b axis)
and is shown in Fig. 9(c).
3.6. Salt solvate of triamterene with azelaic acid (1eDMSO)
The salt solvate 1eDMSO is obtained from a DMSO
solution by dissolving the LAG product of 1 and e in a 2:1
ratio. The asymmetric unit of the resulting crystal structure is
shown in Fig. S7 and contains two molecules each of 1 and
DMSO along with one e acid molecule in the monoclinic space
group P21/n (see Table 1). Both –COOH groups of azelaic acid
are deprotonated, as seen in 1cDMSO and 1dDMSO.
Hydrogen bond details for 1eDMSO are given in Table S10.
The crystal structure shows molecules of 1eDMSO form a
hydrogen-bonded sheet. Further analysis of the sheet shows
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Figure 10
(a) The cyclic hydrogen-bonded host network. (b) The same network with
each cavity filled with two DMSOmolecules showing the motifs M7, M10,
M8 and M9 (TM18), M8 and M9 (TM19), and M7, M10 and M8 (TM20).
(c) The space-filling model showing the zigzag nature of the 1eDMSO
sheets.
Figure 9
(a) The eight-membered hydrogen-bonded host network with a cavity of
14.9  9.1 A˚ and the same cavity filled with two DMSO molecules as
guests. (b) Motifs M7, M10, M8 and M9 (TM18), M8 and M9 (TM19), and
M7, M10 and M8 (TM20) found in the sheet structure formed by the
host–guest hydrogen-bonded network. (c) The zigzag nature of the sheet
structure seen in 1dDMSO.
that molecules of 1 are joined by M8 motifs to form tapes, as
shown in Fig. 10(a). These tapes are held together by mole-
cules of azelaic acid through M7 motifs utilizing charge-
assisted N+—H  O hydrogen bonds. Motifs M7, M10, M8
and M9 (TM18), M8 and M9 (TM19), and M7, M10 and M8
(TM20) motifs create the hydrogen-bonded network. This
association creates an eight-membered cyclic network with
voids of 15  9.3 A˚ which are filled by two phenyl rings of 1
molecules along with the two DMSO molecules that act as
guests (see Fig. 10b).
Stacking of these cyclic networks (viewed along the c axis)
results in the zigzag hydrogen-bonded sheet structure shown
in Fig. 10(c), and these sheets, in turn, stack using van der
Waals forces to create the complete three-dimensional crystal
structure.
3.7. Salt solvate of triamterene with nicotinic acid
(1fDMSO)
The salt obtained by dissolving a 2:1 LAG (DMSO) sample
of 1 and f crystallizes as a DMSO solvate in the monoclinic
space group P21/n (see Table 1). The resulting asymmetric unit
of the crystal structure is shown in Fig. S8 and contains five
molecules: two molecules of 1, one molecule of f and two
DMSO molecules. In this case, one of the molecules of 1 is
protonated (A) while the other remains neutral (B). A list of
hydrogen bonds for 1fDMSO is included in Table S11.
The crystal structure shows that in the supramolecular tape
formed between 1, f and DMSO, A and B molecules are
connected by M8 motifs in an alternating AB–AB fashion to
produce a basic structural ribbon of 1 molecules to which f
molecules are attached through the common M7 motif
involving N—H  O and N+—H  O hydrogen bonds.
DMSO molecules are connected through M9 motifs, as shown
in Fig. 11(a). Motifs M7, M10, M8 and M9 (TM18), M8 and M9
(TM19), and M7, M10 and M8 (TM20) create the hydrogen-
bonded tape seen in Fig. 11(a).
Extension of this tape in the second dimension, allows
connection between adjacent tapes using weak C—H  O
hydrogen bonds to produce the hydrogen-bonded sheet shown
in Fig. 11(b). Further analysis reveals that the tapes of 1
molecules are stacked in a staggered fashion with the hydro-
phobic phenyl groups arranged at a maximum distance from
each other (Fig. 12a). Essentially, A molecules interact with
the –COO group of nicotinic acid using the M7 motif and an
N—H  N hydrogen bond occurs between the N atom of
nicotinic acid and the 2-amino group of a B molecule with an
H  N distance of 2.30 A˚, as shown in Fig. 12(b).
In the third dimension, molecules are arranged as parallel
zigzag stacked sheets, as seen in the space-filling diagram
shown in Fig. 13.
3.8. Salt solvate of triamterene with ibuprofen (1gDMSO)
The salt obtained between 1 and g crystallizes as a DMSO
solvate in the triclinic space group P1, as shown in Table 1. It is
obtained by dissolving a mixture of 1 and g in a 2:1 ratio in
DMSO. The asymmetric unit is shown in Fig. S9 and contains
four molecules in total: two molecules of 1 along with one each
of g and DMSO. As in 1fDMSO, one of the molecules of 1 is
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Figure 12
(a) Stacking of molecules of 1 to form double hydrogen-bonded chains
through (b) nicotinic acid linkages in 1fDMSO.
Figure 11
(a) The motifs M7, M10, M8 and M9 (TM18), M8 and M9 (TM19), and
M7, M10 and M8 (TM20) that create the hydrogen-bonded tape and (b)
sheet that forms part of the crystal structure of 1fDMSO.
protonated (A), while the other remains neutral (B).
However, in this case, the DMSO molecule is disordered over
two sites with occupancies of 0.9 and 0.1. For the purposes of
the crystal structure refinement, geometric constraints and a
common isotropic displacement parameter for the non-H
atoms were applied to the minor site. A list of hydrogen bonds
is included in Table S12.
The crystal structure of 1gDMSO shows that in the mole-
cular complex the A and B molecules connect through M4
motifs via N—H  N hydrogen bonds to yield AA–BB dimers.
These further link through M11 and M12 motifs to create an
AA–BB–AA zigzag crinkled tape of 1 molecules (Figs. 14 and
21).
The recognition pattern between 1 and g shows that N—
H  N and N—H  O hydrogen bonds through M13 and
M14 motifs hold these molecules together. This is one of the
most striking differences observed in the crystal structure of
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Figure 15
The crinkled tape of molecules of 1 with molecules of coformer g and
solvent DMSO with the motifs M5, M4 and M5 (TM16), M13, M4 and
M13 (TM21), M11, M12 and M14 (TM22), and M11 and M12 (TM23) in
the crystal structure of 1gDMSO.
Figure 13
The three-dimensional packing diagram to show the molecules of 1
arranged as zigzag double ribbons in the crystal structure of 1fDMSO.
Figure 14
The crinkled tape of molecules of 1 observed in the crystal structure of
1gDMSO.
Figure 16
(a) Stacking of molecules of 1, (b) the linking of molecules of 1 using
molecules of g and (c) the specific interactions observed between the
stacked hydrogen-bonded layers of 1 and g as seen in the crystal structure
of 1gDMSO.
1gDMSO in comparison with all adducts described above. In
the previous cases, the M7 motif is found between molecules
of 1 and all previous coformers containing the –COOH group
of a–f. However, in this case, the M7 motif is absent since
molecules of 1 combine to form the M11 motif, as shown in
Fig. 15. At the other end of the combined motif, two molecules
of 1 combine with one O atom of the carboxyl group to form
the M14 motif. The DMSO molecules interconnect with 1
through the M5 motif, as observed in 1aDMSO and
1cDMSO. The motifs M5, M4 and M5 (TM16), M13, M4 and
M13 (TM21), M11, M12 and M14 (TM22), and M11 and M12
(TM23) make up the hydrogen-bonded tape structure seen in
1gDMSO (see Fig. 15 for details).
Further analysis reveals staggered
stacking of the tapes of 1molecules with
the hydrophobic phenyl groups
arranged at a maximum distance from
each other (Fig. 16a). The stacks of 1
connect with each other through g
molecules involving motifs M13 and
M14, which results in the formation of
pseudo-cyclic networks (as shown in
Fig. 16b and highlighted in Fig. 16c).
3.9. Analysis of the hydrogen-bonded
motifs in 1 and the reported adducts
(1a–g)
Overall, 14 different motifs have been
observed in 1 and the reported adducts
1a–gDMSO (see Figs. 17 and 19). It is
recognized that the standard graph-set
notation Gad(n) introduced by Etter
(1991) and described in Bernstein et al.
(1995) is not sufficient to accurately
describe the interactions found in this
study, since various ways of forming the
same graph set are possible depending
upon the specific functional groups
involved.
As a result, the concepts of motif and
supramolecular synthon have been
developed and are used throughout this
discussion. Additionally, combined
(tape) motifs are identified because of
the combination of individual motifs in
different structural arrangements.
A survey of the CSD (Version 5.36;
ConQuest Version 1.18) was conducted
in order to better understand the like-
lihood of these motifs and putative
supramolecular synthons occurring in
other adducts similar in molecular
structure to those found in this study.
3.9.1. Hydrogen-bonded motifs
between triamterene (1) molecules.
Molecules of 1 are hydrogen bonded by
dimeric N—H  N hydrogen bonds
between the N atoms at positions 1 and
3 in combination with 2-amino groups
creating the M1 motif or supramole-
cular R22 8ð Þ synthon S1 (see Fig. 18). The
M3 motif is created by interaction
between the N atoms at position 8 and
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Figure 17
Hydrogen-bonded motifs between molecules of 1 observed in this study.
the 7-amino groups of molecules of 1 on adjacent tapes and
may be described as the supramolecular R22 8ð Þ synthon S1. The
other homodimeric motifs only found in the salt solvates
between molecules of 1 are M4 and M8 and it is clear from Fig.
17 that they all originate by utilizing different positions of the
1 molecule, but also that they may all be represented by the
supramolecular R22 8ð Þ synthon S1.
The M2 motif joins three molecules of 1 utilizing the N
atoms at positions 1, 3 and 8, and the 2- and 4-amino groups,
and creates the supramolecular R33ð10) synthon S2 (see
Fig. 18).
The M11 and M12 motifs are unique in this study and exist
between two molecules of 1 in 1gDMSO, one of which is
protonated (A) while the other is neutral (B). M11 and M12
both possess N+—H  N and N—H  N hydrogen bonds and
are represented by the supramolecular
R22 8ð Þ synthon S3 (Fig. 18).
Although they have the same graph-
set descriptor and indeed the same
hydrogen bonds, they represent
different supramolecular synthons since
they utilize different positions on the
molecules of 1 involved in their crea-
tion.
The seven motifs found between 1
molecules reported here are shown in
Fig. 17.
A CSD analysis undertaken by
Delori, Suresh & Pedireddi (2013)
revealed that molecules containing the
N1—C1—NH2 functionality had a high
propensity to form supramolecular
synthon S1. In the present study, a
search of the CSD shows that, in the
solid state, 52.97% (989 out of 1867) of
the crystal structures containing this
functionality do form supramolecular
synthon S1. Indeed, the largest number
of motifs (M1, M3, M4 and M8)
between molecules of 1 in this study are
represented by this supramolecular
synthon (see Fig. 18). Supramolecular
synthon S2 is extremely rare and found
in only two structures (0.21%) out of
the 918 possible crystal structures in the
CSD. Finally, the supramolecular
synthon S3 is represented by 1.96% (25
structures out of a possible 1277)
suitable crystal structures in the CSD.
The various putative supramolecular
synthons described in this section are
shown in Fig. 18.
3.9.2. Hydrogen-bonded motifs
involving triamterene–solvent (1–
solvent) and triamterene–coformer
(1–coformer) interactions. The M5
and M9 motifs occurring between 1 and
the solvent (DMSO), and the M6, M7,
M10, M13 and M14 motifs resulting
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Figure 19
Hydrogen-bonded motifs of 1–solvent and 1–coformer molecules observed in this study.
Figure 18
Supramolecular synthons observed in this study.
from the interaction between 1 and the coformers (a–g) are
shown in Fig. 19.
M5 involves the interaction of three molecules including the
O atom of DMSO using two N—H  O hydrogen bonds with
the 2- and 4-amino groups of different molecules of 1 and a
further N—H  N hydrogen bond between the N3 atom and
the 4-amino group of adjacent molecules of 1. M5 may be
represented by the supramolecular R23 8ð Þ synthon S4 as seen in
Fig. 20 and although M9 is also represented by the supramo-
lecular R23 8ð Þ synthon S4, it clearly differs from M5 in the
position of one of the amino groups on the molecule of 1.
The M6 and M10 motifs seen in Fig. 19 and represented by
the supramolecular R23 8ð Þ synthon S5 in Fig. 20 are formed
through charge-assisted N+—H  Oand neutral N—H  N
hydrogen bonds between 1 and the carboxyl group of the acid.
Both of these motifs utilize the protonated N atom of 1 at
position 1 and the N atom at position 8, but the N—H  N
hydrogen bond has a different composition in each motif,
involving the 7-amino group for M6 and the 4-amino group for
M10.
The unique M13 motif or supramolecular R23 8ð Þ synthon S6
(see Fig. 20) is only found in 1gDMSO. This motif results from
an N—H  N hydrogen bond between atom N3 and the 4-
amino group, along with two N—H  O hydrogen bonds
involving the 2-amino group of one molecule of 1 and the 4-
amino group of the other. Similarly, the unique M14 motif or
supramolecular R23 8ð Þ synthon S5 (Fig. 20) in 1gDMSO results
from three hydrogen bonds, but in this case, two charge-
assisted N—H  O hydrogen bonds and one N—H  N
hydrogen bond.
In the M7 motif or supramolecular R22 8ð Þ synthon S7 (Fig.
20) the most basic protonated N atom (N1) and the 2-amino
group of 1 interact with the complementary carboxyl group
through charge-assisted N+—H—O- and N—H  O hydrogen
bonds. The resulting M7 heterodimer is found to be the most
frequent motif seen in this study as it is present in all crystal
structures except 1gDMSO.
The CSD search carried out as part of this study revealed
that supramolecular synthons S4 and S5 have a low probability
of occurrence (1.68% each) of all the possible synthons in all
structures; supramolecular synthon S6 has a frequency of
occurrence of 8.41%, while supramolecular synthon S7 has by
far the highest frequency of occurrence at 73.45% (617 out of
840 possible crystal structures). These figures are supported by
an earlier CSD study by Allen et al. (1999) that showed the
probability of forming the R22 8ð Þ supramolecular synthon as ca
95% for monocarboxylic acids and 85% for dicarboxylic acids
when no other competing hydrogen-bond donors or acceptors
are present. More recently, a study by Delori, Galek et al.
(2013) using knowledge-based hydrogen bond propensity calc-
ulations (HBPCs)demonstrated thehighprobabilityof creating
the R22 8ð Þ supramolecular synthon when looking at an anti-
malarial drug, i.e. pyrimethamine, and various carboxylic acids.
3.9.3. Hydrogen-bonded tape motifs in triamterene and
adducts (1a–g). The TM15 tape motif is specific to 1 and is
formed by a combination of three motifs, i.e.M2, M1 and M2.
It is thought the interaction between molecules of 1 to create
the M1 motif exposes sites rich in hydrogen-bond donors, i.e.
the 2-amino groups of two interacting molecules of 1. The
hydrogen-bond acceptor sites on adjacent molecules of 1, i.e.
the N1, N3 and N8 atoms, interact with these rich hydrogen-
bond donors creating the M2 motif and, therefore, the M15
tape motif with the graph-set notation R44 20ð Þ. The exposed
hydrogen-bond donor sites at the 2- and 4-amino groups also
result in the formation of the M4 motif and so can interact
with the O atom of DMSO by M5 in adducts 1a and 1cDMSO.
The three motifs (M5, M4 and M5) combine to form the
TM16 tape motif with the graph-set notation R23 16ð Þ. In the
TM17 tape motif, the protonated N1 atoms of two molecules
of 1 interact with the 2- and 7-amino and the carboxyl groups,
resulting in the formation of a tape motif, which is a combi-
nation of five motifs (M7, M6, M3, M6 and M7).
In the TM18 tape motif, the exposed hydrogen-bond donor
sites that result from M8 at the 2-amino group and the
protonated N1 atom are satisfied by the O atom of DMSO and
the carboxyl group of the acid to give M9, M10 and M7 motifs.
The TM18 tape motif is therefore composed of four motifs
(M7, M10, M8 and M9) and may be represented by the graph-
set notation R34 20ð Þ. The TM19 tape motif is represented by
the graph set notation R23 12ð Þ and is a combination of M8 and
M9. TM20 resembles TM18 since it contains M7, M10 and M8
in the same order but with the difference that M9 (present in
M18) is absent and therefore TM20 may be represented by the
graph-set descriptor R33 16ð Þ.
The TM21 and TM22 tape motifs are unusual since they are
present in only one of the adducts (1gDMSO, see Fig. 15) seen
in this study. The TM21 tape motif contains motifs M13, M4
and M13, with donor sites at the 2- and 4-amino groups which
are satisfied by an O of the carbonyl group and create the
R24 16ð Þ graph set. The TM22 tape motif also contains three
motifs (M11, M12 and M14), with donor sites belonging to the
2- and 7-amino groups along with the protonated N1 atom
hydrogen bonded to an O atom of the carboxyl group and the
N1 atom of the adjacent neutral molecule of 1.
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Figure 20
Supramolecular synthons between 1 and solvent, and 1 and coformer
molecules observed in this study.
The combined motifs found in 1 and the adducts of 1 are
shown in Fig. 21.
4. Summary
The motifs and tape motifs observed in
the hydrogen-bonded ribbons of 1 and
the various adducts (1a-gDMSO) are
summarized in Fig. 22. By applying
colour to represent the motifs, a method
of notation (but not mathematical
rigour) is developed that better repre-
sents the structures. By representing the
crystal structure as a repeating sequence
of ring structures and by systematically
listing the sequence of rings, a pattern is
defined. Although this is not the whole
story, these patterns can be used to
compare the structures.
From Fig. 22 it can be seen that the
crystal structures in this study can be
divided into four groups.
(i) 1 can be seen to be composed of
only 1–1 interactions. The M1 and M2
motifs combine to form the TM15 tape
motif and the hydrogen-bonded ribbon.
M3 forms an essential connection
between adjacent ribbons in 1 that
allows the hydrogen-bonded sheet to be
formed by extension of the structure in
the direction orthogonal to that of the
ribbon. Interestingly, M3 is also found in
1aDMSO and 1cDMSO, but this time
within the ribbon structure and it may
therefore be regarded as a synthon.
(ii) 1aDMSO and 1cDMSO contain
the motifs M3, M4, M5, M6 and M7 that
combine to form TM16 and TM17.
These crystal structures contain very
similar sheet structures and, looking at
the unit-cell dimensions, 1aDMSO and
1cDMSO may be regarded as being
isostructural.
(iii) 1bDMSO, 1dDMSO, 1eDMSO
and 1fDMSO contain motifs M7, M8,
M9 and M10 that combine to form
TM18, TM19 and TM20. Interestingly,
1bDMSO, 1dDMSO and 1eDMSO
have similar hydrogen-bonded sheets
which differ considerably from
1fDMSO that contains a hydrogen-
bonded double ribbon.
(iv) 1gDMSO has a unique connec-
tivity and crystal structure resulting
from (in part) the presence of the
unique 1–1 motifs M11 and M12 that
combine to form a unique dimer struc-
ture (TM23).
Furthermore, it can be seen from Fig. 22 that the hydrogen-
bonded motif M7 is present in all cases except for 1gDMSO.
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Figure 21
Supramolecular tape motifs found in 1 and adducts of 1 observed in this study.
This is one of the motifs predicted by the supramolecular
synthon approach and pKa discussed earlier (see Fig. 2 for
details). The CSD search outlined in x3.9.2 shows the prob-
ability of occurrence of M7 in molecules containing the
functional groups required to create this motif, such as pyri-
methamine (Delori, Galek et al., 2013) and the triazines (Bhatt
et al., 2009) and carboxylic acids, is quite high at 73.45%.
To confirm the position of the proton in 1gDMSO, a further
CSD study was undertaken to look for similar three-centred
dimers in the presence of carboxylic acids. Among the results
of this search, the hemicytosinium duplexes described by
Perumalla et al. (2013) were found. In this paper, experiments
were performed to determine the ability of cytosine to form
salts with a series of acids. It was stated that the cytosinium ion
was present only with acids of a pKa > 4.2 and less strong acids
were unable to disrupt the relatively stable duplex structure. It
is proposed that a similar kinetic mechanism is found in this
study where triamterene forms a stable three-centred duplex
(hemitriamterenium) containing the M11 and M12 motifs that
cannot be disrupted by ibuprofen with a pKa value of 5.2 but
can form the triamterenium ion with the stronger carboxylic
acids in the pKa range 4.2–4.76.
5. Conclusions
The salt solvate adducts 1a–gDMSO were prepared using
conventional screening techniques, i.e. LAG and SEC. Adduct
formation was confirmed by SCXRD, PXRD, DSC and TGA.
The results are in accordance with the modified pKa rule
proposed by Cruz-Cabeza (2012). To overcome some of the
limitations of graph-set theory, the concepts of motif, tape
motif and supramolecular synthon are introduced to describe
the crystal structures since it has been established that mole-
cules of 1 can adopt different orientations corresponding to
the same graph-set descriptor. It is noteworthy that the M1
motif is seen only in the crystal structure of 1 but is not
observed in any of the other crystal structures because of its
replacement by M7 in 1a–fDMSO and M11 in 1gDMSO. The
present study and the CSD survey carried out by Delori,
Suresh & Pedireddi (2013) both suggest M7 to be a very robust
motif. In fact, the M7 motif is present in all the reported
adducts found in this study except for 1gDMSO. It should also
be noted that this is the same motif proposed in Fig. 2,
resulting from the crystal engineering approach which
emphasizes the identification of systematic patterns of
hydrogen bonds from known crystal structures. Overall seven
adducts (1a–g. DMSO) containing 14 motifs, 8 supramolecular
tape motifs and 7 supramolecular synthons are reported and
their structural relationships explored. The anomalous beha-
viour of 1 gDMSO is explained by the inability of ibuprofen
to disrupt the stable hemitriamterenium duplex.
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